The Association of Inappropriate Drug Use with Hospitalisation and Mortality
- 453 Downloads
Background and objective
Inappropriate prescribing is an important and possibly preventable risk factor for adverse drug reactions (ADRs) in the elderly, and hospital-based studies have shown that a large proportion of admissions is a result of ADRs. However, little is known about how inappropriate drug use (IDU) affects the elderly at the population level. The aim of this study was to explore possible associations of IDU with acute hospitalisation and mortality in an elderly population during 3 years of follow-up.
Patients and methods
Data from a rural, population-based, longitudinal cohort study within the Kungsholmen Project, Sweden, were used. 785 participants, ≥75 years of age, had complete data on drug use and selected covariates collected during baseline investigation from 1995 to 1998, and were included in the study. Hospitalisation and mortality data during 3 years after inclusion were collected. IDU was assessed at baseline using consensus-based criteria applicable to available data (derived from Beers’ criteria, Canadian criteria and clinical indicators of drug-related morbidity in older adults) with the addition of potentially dangerous drug duplication and additional potentially hazardous drug-drug interactions. IDU was defined as presence of at least one inappropriate drug regimen according to the study criteria. Logistic regression and proportional hazard models were used, respectively, to study the association of IDU with hospitalisation and mortality.
Drugs were used on a regular or ‘as needed’ basis by 91.6% of the study population, with a mean of 4.4 drugs per person. IDU was common, with a prevalence of 18.6% and was associated with increased risk of at least one acute hospitalisation in community-living elderly, after adjustment for age, sex, education, comorbidity, dependency in activities of daily living (ADL) and smoking. The odds ratio was 2.72 (95% CI 1.64, 4.51). No association with mortality was found, after adjustment for age, sex, housing, education, comorbidity, ADL-dependency, smoking and body mass index.
Polypharmacy and IDU are common among the elderly and IDU is associated with acute hospitalisation in community-living elderly. Although causality cannot be established with this study design, the results are consistent with the high prevalence of drug-related hospital admissions found in hospital-based studies. Our results indicate that it is desirable with current knowledge, to reduce IDU through information to physicians and careful prescribing.
KeywordsNursing Home Disopyramide Inappropriate Drug Sheltered Housing Drug Utilisation Review
This study was supported by The National Board of Health and Welfare, Sweden; Forum for Research and Development (FOU-forum), The County Council of Gävleborg, Sweden; The Federation of Swedish County Councils (Landstingsförbundet), Sweden, Dnr 1297/00; The National Corporation of Swedish Pharmacies’ Fund for Research and Studies in Health Economics and Social Pharmaceutics (Stiftelsen Apoteksbolagets fond för forskning och studier i hälsoekonomi och socialfarmaci), Sweden.
The authors have no conflicts of interest directly relevant to this review.
- 5.Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002; 42(6): 847–57Google Scholar
- 22.WHO Collaborating Centre for Drug Statistics and Methodology. Guidelines for ATC classification and DDD assignment. Oslo, Norway: World Health Organization, 1995Google Scholar
- 26.Sjöqvist F. Drug interactions [in Swedish]. In: FASS. Läkemedel i Sverige. Forteckning over humanläkemedel. Stockholm, Sweden: LINFO Läkemedelsinformation AB, 1997: 1220–73Google Scholar
- 27.Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic meta-analysis. I: psychotropic drugs. J Am Geriate Soc 1999; 47(1): 30–9Google Scholar
- 29.Miller EA, Weissert WG. Predicting elderly people’s risk for nursing home placement, hospitalization, functional impairment, and mortality: a synthesis. Med Care Res Rev 2000, 97Google Scholar
- 35.Jassal V, Fillit H, Oreopoulos DG. Diseases of the aging kidney. In: Tallis R, Fillit H, Brocklehurst JC, editors. Brocklehurst’s textbook of geriatric medicine and gerontology. 5th ed. London: Churchill Livingstone, 1998: 949–71Google Scholar
- 42.Biverkningsrapportering i Sverige 1998 [in Swedish]. Information från Läkemedelsverket (Information from the Medical Product Agency, Sweden) 1999; 10(4): 23 [online]. Available from URL: http://www.mpa.se/biverkningar/biv99/bivtabell_-i.htm. [Accessed 2004 Nov 21]
- 43.Table 60: population by sex, marital status and age by single years. In: Statistical yearbook of Sweden. Örebro, Sweden: Statistics Sweden, 2000: 57–8Google Scholar